V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310005492 | 310002549 | 1.82 | 0 | Palliative (P) | 2017-03-03 | 2017-03-10 | CYTARABINE + DAUNORUBICIN | N | N | 310022763 | BEP |
| 310005493 | 310002549 | 1.64 | 60 | Palliative (P) | 2019-03-05 | 2019-03-14 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | null | 310022763 | BEVACIZUMAB |
| 310005494 | 310002550 | null | 109 | Curative (C) | 2017-11-25 | 2017-12-10 | IVE | N | N | 310022823 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA |
| 310005495 | 310002550 | 1.59 | 77.699 | Palliative (P) | 2015-03-11 | 2015-03-12 | CVP R + GEMCITABINE | 01 | N | 310022823 | ICON8B TRIAL |
| 310005496 | 310002551 | 1.67 | 86 | Curative (C) | 2016-10-17 | 2016-10-17 | CARBOPLATIN + RT | Y | N | 310022826 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE |
| 310005497 | 310002552 | null | 60.2 | Palliative (P) | 2016-04-11 | 2016-05-23 | Carboplatin+Fluorouracil 4 or 5 day | N | null | 310022843 | LENALIDOMIDE |
| 310005498 | 310002552 | 1.72 | 83.5 | Curative (C) | 2018-07-23 | 2018-07-27 | Bendamustine+Rituximab(Sub Courses) | N | N | 310022843 | IVE |
| 310005499 | 310002552 | 1.9 | 77 | Palliative (P) | 2015-08-04 | 2015-08-05 | GEMCITABINE + VINORELBINE | 2 | N | 310022843 | CARBO + FLUOROURACIL |
| 310005500 | 310002553 | 1.73 | 67.1 | null | 2016-05-28 | 2016-06-18 | Doxorubicin + Ifosfamide | null | N | 310022893 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE |
| 310005501 | 310002553 | 1.67 | null | Palliative (P) | 2018-06-04 | 2018-06-11 | CAPECITABINE + RT | 02 | null | 310022893 | IDARAM |
| 310005502 | 310002554 | null | 96 | Curative (C) | 2018-04-30 | 2018-05-01 | MTX HD + PROCARBAZINE + VINCRISTINE | 02 | N | 310022924 | CHLORAMBUCIL |
| 310005503 | 310002555 | 1.78 | 56.9 | null | 2016-02-16 | 2016-02-17 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310022967 | BEVACIZUMAB + CARBO |
| 310005504 | 310007059 | 1.62 | 49 | Palliative (P) | 2018-04-05 | 2018-04-05 | FEC 100 + DOCETAXEL | N | N | 310022984 | PAZOPANIB |
| 310005505 | 310002556 | 1.71 | 107.6 | Palliative (P) | 2015-06-11 | 2015-06-11 | ECarboX | N | N | 310023019 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 310005506 | 310002557 | 1.6 | 79.9 | Curative (C) | 2015-02-09 | 2015-02-15 | CYCLOPHOSPHAMIDE | 2 | N | 310023021 | CARBOPLATIN + VINORELBINE |
| 310005507 | 310002558 | 1.57 | 56.8 | Neo-adjuvant (N) | 2018-10-20 | 2018-10-20 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 310023035 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 310005508 | 310002558 | 1.53 | 62.4 | Palliative (P) | 2018-03-03 | 2018-03-16 | Doxorubicin + Ifosfamide | Y | N | 310023035 | RCEOP |
| 310005509 | 310002559 | 1.61 | 95 | Palliative (P) | 2015-04-06 | 2015-07-04 | IVAC | N | N | 310023055 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE |
| 310005510 | 310002560 | 1.63 | 75.2 | Palliative (P) | 2018-10-28 | 2018-10-28 | IVE | N | N | 310023113 | CYCLOPHOSPHAMIDE |
| 310005511 | 310002561 | 1.55 | 56.7 | Curative (C) | 2017-06-09 | 2017-06-16 | EC | N | N | 310023141 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310005512 | 310002562 | 1.68 | 0 | Disease modification (D) | 2015-01-06 | 2015-01-06 | FEC 60 or 75 | N | null | 310023161 | CISPLATIN + DOCETAXEL |
| 310005513 | 310002563 | 1.68 | null | Neo-adjuvant (N) | 2016-05-16 | 2016-05-18 | IVE | N | N | 310023181 | ERLOTINIB |
| 310005514 | 310002564 | 1.71 | 77.3 | Palliative (P) | 2014-08-01 | 2014-08-01 | OCTREOTIDE | N | N | 310023203 | BLEOMYCIN |
| 310005515 | 310002565 | null | 99.4 | Disease modification (D) | 2015-11-22 | 2016-02-21 | FLUOROURACIL + IRINOTECAN | N | N | 310023212 | SUNITINIB |
| 310005516 | 310002565 | null | 80.3 | Curative (C) | null | 2017-01-14 | Alemtuzumab(INTRAVENOUS) | null | null | 310023212 | CETUXIMAB |
| 310005517 | 310002566 | 1.48 | 53.75 | Disease modification (D) | null | 2017-12-01 | BEVACIZUMAB + CARBO | N | N | 310023222 | CAPECITABINE + TEMOZOLOMIDE |
| 310005518 | 310002567 | 1.67 | 66 | Palliative (P) | 2017-02-24 | 2017-03-20 | Folfirinox | N | N | 310023231 | CARBOPLATIN + LIPOSOMAL DOX |
| 310005519 | 310002568 | 0 | 64.4 | Disease modification (D) | 2017-06-05 | 2017-07-29 | CYCLOPHOSPHAMIDE + FILGRASTIM | 02 | N | 310023237 | BEP |
| 310005520 | 310002569 | 0 | null | Curative (C) | 2016-03-05 | 2016-03-05 | CARBOPLATIN + VINORELBINE | Y | N | 310023248 | BEVACIZUMAB |
| 310005521 | 310002569 | 0 | 59.65 | Palliative (P) | 2016-06-02 | 2016-06-05 | OXALIPLATIN | 1 | N | 310023248 | CYCLO + ETOPOSIDE + VINCRISTINE |
| 310005522 | 310002569 | 1.73 | 76 | Palliative (P) | 2013-09-08 | 2013-09-11 | Cisplatin + Pemetrexed | N | N | 310023248 | IFOSFAMIDE |
| 310005523 | 310002569 | 1.58 | 0 | Palliative (P) | null | 2017-12-16 | Bevacizumab 7.5mg/kg | N | N | 310023248 | OCTREOTIDE |
| 310005524 | 310002569 | 1.81 | 95.6 | Palliative (P) | 2018-06-12 | 2018-07-04 | Carboplatin+Fluorouracil 4 or 5 day | 02 | Y | 310023248 | PMITCEBO-R |
| 310005525 | 310002570 | 1.53 | 96 | Palliative (P) | 2017-04-29 | 2017-05-29 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310023406 | OLAPARIB |
| 310005526 | 310007063 | 1.62 | null | Curative (C) | 2015-04-19 | 2015-04-27 | EC | null | null | 310023408 | METHOTREXATE HIGH DOSE |
| 310005527 | 310007063 | 1.83 | 86.6 | Palliative (P) | 2014-03-08 | 2014-03-16 | CYTARABINE + DAUNORUBICIN | N | N | 310023408 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 310005528 | 310002571 | 1.76 | 76.5 | Palliative (P) | 2015-12-07 | 2015-12-07 | GEMCITABINE + VINORELBINE | 02 | N | 310023478 | IVE |
| 310005529 | 310002572 | null | 90.3 | Adjuvant (A) | null | 2018-02-04 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | null | 310023481 | SORAFENIB |
| 310005530 | 310007064 | 1.58 | 59.7 | Curative (C) | 2015-12-07 | 2015-12-08 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 310023482 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310005531 | 310009291 | 1.65 | null | Palliative (P) | 2017-01-13 | 2017-01-13 | MTX HD + PROCARBAZINE + VINCRISTINE | null | null | 310023501 | DOCETAXEL |
| 310005532 | 310010460 | 1.82 | 97 | Palliative (P) | 2017-05-11 | 2017-05-13 | R GCVP | 02 | Y | 310023527 | CAPECITABINE + CARBOPLATIN |
| 310005533 | 310011108 | 174.3 | 78.5 | Palliative (P) | 2017-12-19 | 2017-12-20 | IVE | 02 | N | 310023555 | CETUXIMAB + OXALIPLATIN + MDG |
| 310005534 | 310011108 | 1.66 | null | Palliative (P) | 2014-10-21 | 2014-12-23 | CARBOPLATIN + VINORELBINE | null | N | 310023555 | EC |
| 310005535 | 310011108 | 1.59 | 75.4 | Neo-adjuvant (N) | 2013-05-13 | 2013-05-25 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 310023555 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE |
| 310005536 | 310011108 | 1.65 | 78 | Neo-adjuvant (N) | null | 2016-02-29 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 310023555 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 310005537 | 310002573 | 1.75 | 67.1 | Palliative (P) | 2019-01-26 | 2019-02-08 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | N | N | 310023630 | SUNITINIB |
| 310005538 | 310002574 | 1.6 | 48.45 | Curative (C) | 2016-09-13 | 2016-09-13 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 02 | N | 310023655 | CYCLOPHOSPHAMIDE |
| 310005539 | 310002574 | 1.95 | 0 | Disease modification (D) | 2017-04-29 | 2017-04-30 | VIDE | N | N | 310023655 | IVAC |
| 310005540 | 310002575 | 1.79 | 11.8 | null | 2016-11-04 | 2016-11-04 | Chlorambucil | 02 | N | 310023666 | IVE |
| 310005541 | 310002575 | 1.76 | 100 | Palliative (P) | 2018-07-12 | 2018-07-31 | IVADo | null | N | 310023666 | IFOSFAMIDE |